Patents Assigned to LUCOLAS-M.D. LTD.
  • Patent number: 11850451
    Abstract: The invention relates to the use of an agent and a composition, respectively, comprising the following active ingredients: a) an aromatase inhibitor and/or a 5-?-reductase inhibitor, b) an antioxidant, and c) hyaluronic acid for cosmetic purposes.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: December 26, 2023
    Assignee: Lucolas-M.D. Ltd.
    Inventor: Alfred Schmidt
  • Patent number: 11052059
    Abstract: The invention describes a combination of at least one aromatase inhibitor selected from the group of chemical-synthetic aromatase inhibitors and aromatase inhibition exhibiting extracts of soya beans and rapeseed, respectively, and at least one plant extract that contains one or more active ingredient substance(s) extracted from the plant, which is(are) selected from the group of 5? reductase type I and/or type II inhibitors and androgen receptor blockers, said combination being contained for example in a composition and having special properties for influencing hair growth. Uses of this combination are also described.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: July 6, 2021
    Assignee: LUCOLAS - M.D. LTD
    Inventor: Alfred Schmidt
  • Patent number: 10835540
    Abstract: The invention relates to the use of a pharmaceutical medication comprising an aromatase inhibitor, preferably a steroidal aromatase inactivator and an antioxidant as effective ingredients for the treatment of sex hormone-dependent diseases. Furthermore, the invention relates to a composition comprising an aromatase inhibitor/—inactivator and ?-lipoic acid and/or extract of green tea containing polyphenols. The combination of an aromatase inhibitor and—inactivator and ?-lipoic acid and/or extract of green tea containing polyphenols is particularly suitable for the treatment of sex hormone-dependent diseases as well as for the treatment of benign tumors such as e.g. lipomatoses as occurring in Madelung's disease.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: November 17, 2020
    Assignee: Lucolas-M.D. Ltd.
    Inventor: Alfred Schmidt
  • Publication number: 20130337091
    Abstract: The invention relates to the use of a pharmaceutical medication comprising an aromatase inhibitor, preferably a steroidal aromatase inactivator and an antioxidant as effective ingredients for the treatment of sex hormone-dependent diseases. Furthermore, the invention relates to a composition comprising an aromatase inhibitor/—inactivator and ?-lipoic acid and/or extract of green tea containing polyphenols. The combination of an aromatase inhibitor and—inactivator and ?-lipoic acid and/or extract of green tea containing polyphenols is particularly suitable for the treatment of sex hormone-dependent diseases as well as for the treatment of benign tumors such as e.g. lipomatoses as occurring in Madelung's disease.
    Type: Application
    Filed: January 31, 2012
    Publication date: December 19, 2013
    Applicant: LUCOLAS-M.D. LTD.
    Inventor: Alfred Schmidt
  • Publication number: 20130309217
    Abstract: The invention relates to the use of an agent and a composition, respectively, comprising the following active ingredients: a) an aromatase inhibitor and/or a 5-?-reductase inhibitor, b) an antioxidant, and c) hyaluronic acid for cosmetic purposes.
    Type: Application
    Filed: January 30, 2012
    Publication date: November 21, 2013
    Applicant: LUCOLAS-M.D. LTD.
    Inventor: Alfred Schmidt